StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Stock Performance
Shares of Milestone Scientific stock opened at $1.03 on Friday. The stock has a market cap of $79.54 million, a P/E ratio of -10.30 and a beta of 1.08. The stock’s fifty day moving average is $0.93 and its 200 day moving average is $0.76. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10.
Milestone Scientific (NYSE:MLSS – Get Free Report) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million during the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.
Insider Transactions at Milestone Scientific
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Election Stocks: How Elections Affect the Stock Market
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- How to Invest in the FAANG Stocks
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Upcoming IPO Stock Lockup Period, Explained
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.